(Q35849907)

English

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l

scientific article published on 11 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

3

object named as

Paul S Gaynon

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

9

object named as

Nyla A Heerema

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Yousif Matloub

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Susan Lindemulder

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Harland Sather

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Mei La

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Emmett Broxson

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Rochelle Yanofsky

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Raymond Hutchinson

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

James Nachman

10

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Marilyn Blake

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Linda M Wells

12

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

April D Sorrell

13

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Margaret Masterson

14

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

John F Kelleher

15

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Linda C Stork

16

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Children's Oncology Group

17

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

language of work or name

0 references

publication date

11 April 2006

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

108

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1165-1173

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Intrathecal chemotherapy with antineoplastic agents in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Prevention and treatment of meningeal leukemia in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Long-term sequelae of therapy for childhood acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Patient subsets and variation in therapeutic efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. A 13-year experience from the Dana-Farber Cancer Institute and the Children's Hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Long-term evaluation of a CNS prophylaxis trial--treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Treatment intensity and outcome for children with acute lymphocytic leukemia of standard risk. A Pediatric Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Neurotoxicity due to central nervous system therapy for childhood leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Prevention of meningeal leukemia. Review of 20 years of research and current recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Second neoplasms after acute lymphoblastic leukemia in childhood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Combination intrathecal therapy for meningeal leukemia: two versus three drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

27 July 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Some practical aspects of the interim monitoring of clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Interim analysis: the alpha spending function approach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Power considerations for testing an interaction in a 2 x k factorial design with a failure time outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Pharmacokinetics and metabolism of cytosine arabinoside in the central nervous system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895867

24 September 2018

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy: The antagonism of methotrexate and cytosine arabinoside

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system prophylaxis in leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytosine arabinoside cerebrospinal fluid kinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology and pathogenesis of CNS leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PCR assessment of bone marrow status in ‘isolated’extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic methotrexate exposure is greater after intrathecal than after oral administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensification of Therapy for Children With Lower-Risk Acute Lymphoblastic Leukemia: Long-Term Follow-Up of Patients Treated on Children’s Cancer Group Trial 1881

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of combination chemotherapy in vivo and in culture with l- -D-arabinofuranosylcytosine and 1-formylisoquinoline thiosemicarbazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of drugs inhibiting different steps in the synthesis of DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994

1 reference

https://pubmed.ncbi.nlm.nih.gov/16609069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2005-12-011809

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35849907&oldid=1567995827"